Enhancing Automated Ion Channel Electrophysiology to Support Drug Discovery

11:30 am - Wednesday 23rd September 2026

  • Exploring the transformative role of automated electrophysiology platforms in high-throughput ion channel screening for drug discovery 
  • Detailing the application of these technologies in early safety profiling to efficiently detect cardiotoxic and neurotoxic risks, with a goal to minimizing late-stage attrition 
  • Discussing strategic screening approaches to identify potent, selective, and safe modulators, enhancing mechanistic understanding and expediting therapeutic development 

Speakers:

Group Leader & Scientific Leader
GlaxoSmithKline